MICAL2 promotes breast cancer cell migration by maintaining epidermal growth factor receptor (EGFR) stability and EGFR/P38 signalling activation

Publisher： John Wiley & Sons Inc

E-ISSN： 1748-1716|222|2|apha.12920-apha.12920

ISSN： 1748-1708

Source： ACTA PHYSIOLOGICA (ELECTRONIC), Vol.222, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidermal Growth Factor Receptor (EGFR) Inhibitors in Gastrointestinal Cancer

By  

Oncology Research and Treatment, Vol. 29, Iss. 3, 2006-03 ,pp. : 99-105

Karger

Access to resources Recommend Favorite

Histologie-basierter Algorithmus der molekularen Diagnostik des epidermalen Wachstumsfaktor-Rezeptorgens (Epidermal Growth Factor Receptor, EGFR) beim nicht-kleinzelligen Lungenkarzinom (non-small cell lung cancer, NSCLC) *

By Popper Helmut  

Wiener klinische Wochenschrift, Vol. 123, Iss. 9-10, 2011-05 ,pp. : 316-321

Springer Publishing Company

Access to resources Recommend Favorite

Mapping and microsatellite marker development for the porcine leukemia inhibitory factor receptor (LIFR) and epidermal growth factor receptor (EGFR) genes

By  

Cytogenetic and Genome Research, Vol. 98, Iss. 2-3, 2003-04 ,pp. : 216-220

Karger

Access to resources Recommend Favorite

The Role of the Epidermal Growth Factor Receptor in Breast Cancer

By Chan Samuel   Hill Mark   Gullick William  

Journal of Mammary Gland Biology and Neoplasia, Vol. 11, Iss. 1, 2006-01 ,pp. : 3-11

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Human Epidermal Growth Factor Receptor 2 (HER2) in the Treatment of Breast Cancer: Recent Advances and Future Directions

By  

Reviews on Recent Clinical Trials, Vol. 2, Iss. 2, 2007-05 ,pp. : 111-116

Bentham Science Publishers

Access to resources Recommend Favorite